Ys an important role in the pathogenesis of POI has been

Ys an important role in the pathogenesis of POI has been supported by increasing experimental evidences. In POI animal models, scientists have observed inflammatory responses characterized by leukocyte infiltration in the intestinal muscularis, and elevated levels of inflammatory mediators in tissues and plasma 24 h after abdominal surgery [2,7,8]. Kalff et al. [8] demonstrated the increased mRNA and protein expression of intercellular adhesion molecule 1 (ICAM-1) and pselectin in the intestinal muscularis of POI, and the introduction of ICAM-1 antibody may prevent the aggregation of monocytes andInflammation CB1 Receptor in Postoperative Ileusneutrophils in the intestinal muscularis and ameliorate the functional disorder of jejunum circular muscle during POI. In the previous work, we confirmed this inflammatory response in the intestinal muscularis, and showed elevated myeloperoxidase (MPO) activity indicating increased numbers of neutrophils during POI [9]. All of these studies explored the role of inflammatory responses in POI at its early stage, few hours after the surgical operations [10]. The cannabinoid system is involved in GI motility and secretion [11,12]. In keeping with these observations, cannabinoid receptor-1 (CB1) was shown to be localized in the GI tract of many species, including humans [11?5]. CB1 was also shown to be MedChemExpress ML-281 present in neurons of the myenteric and submucosal plexus of the ileum and the colon [16]. Activation of CB1 reduces electrically induced contractions and movements [17,18] and slows motility throughout the gut [19,20]. In addition, the anti-inflammatory potential of cannabinoids has been of interest since their discovery in mammalians [16]. Enhancement of 1315463 cannabinoid signaling and increased expression of CB1/CB2 receptors and/or endocannabinoid levels were observed following inflammatory stimuli in animals and in intestinal biopsies from patients with gut inflammatory disorders [21?3]. Several groups also showed that cannabinoids had exerted anti-inflammatory actions in the gut by activating CB1 receptor, and that the mechanism of action had involved inhibition of chemokines and proinflammatory cytokines, which were mainly released from macrophage and mast cells [24,25]. Considering that CB1 activation slows GI motility and possesses anti-inflammatory potential as well, we aimed to investigate the involvement and role of CB1 in POI and the possible mechanisms. Specifically, we hypothesized that intestinal and systemic inflammatory responses associated with POI were increased in CB1deficient mice [26], and design a study to elucidate whether activation of CB-1 receptors may serve as a potential target for prevention or treatment of POI.Methods Model of Postoperative IleusAdult female CB1-deficient (CB1?? mice and wild-type littermates (body weight of 25?5 g) in C57BL/6N background as described previously [26] were used in this study. These mice were kept in-house for at least 1 week prior to experiments. Before and during the experiments the animals were housed and maintained under controlled environmental conditions: in plastic sawdust floor cages at constant temperature (22uC) and a 12:12-h light ark cycle with free access to standard laboratory chow and tap water. The animal experiments were carried out in accordance with the national and international guidelines as outlined in the Guide for the Care and Use of Laboratory Animals, using the protocols approved by the Government of Tubastatin-A Bavaria animal use.Ys an important role in the pathogenesis of POI has been supported by increasing experimental evidences. In POI animal models, scientists have observed inflammatory responses characterized by leukocyte infiltration in the intestinal muscularis, and elevated levels of inflammatory mediators in tissues and plasma 24 h after abdominal surgery [2,7,8]. Kalff et al. [8] demonstrated the increased mRNA and protein expression of intercellular adhesion molecule 1 (ICAM-1) and pselectin in the intestinal muscularis of POI, and the introduction of ICAM-1 antibody may prevent the aggregation of monocytes andInflammation CB1 Receptor in Postoperative Ileusneutrophils in the intestinal muscularis and ameliorate the functional disorder of jejunum circular muscle during POI. In the previous work, we confirmed this inflammatory response in the intestinal muscularis, and showed elevated myeloperoxidase (MPO) activity indicating increased numbers of neutrophils during POI [9]. All of these studies explored the role of inflammatory responses in POI at its early stage, few hours after the surgical operations [10]. The cannabinoid system is involved in GI motility and secretion [11,12]. In keeping with these observations, cannabinoid receptor-1 (CB1) was shown to be localized in the GI tract of many species, including humans [11?5]. CB1 was also shown to be present in neurons of the myenteric and submucosal plexus of the ileum and the colon [16]. Activation of CB1 reduces electrically induced contractions and movements [17,18] and slows motility throughout the gut [19,20]. In addition, the anti-inflammatory potential of cannabinoids has been of interest since their discovery in mammalians [16]. Enhancement of 1315463 cannabinoid signaling and increased expression of CB1/CB2 receptors and/or endocannabinoid levels were observed following inflammatory stimuli in animals and in intestinal biopsies from patients with gut inflammatory disorders [21?3]. Several groups also showed that cannabinoids had exerted anti-inflammatory actions in the gut by activating CB1 receptor, and that the mechanism of action had involved inhibition of chemokines and proinflammatory cytokines, which were mainly released from macrophage and mast cells [24,25]. Considering that CB1 activation slows GI motility and possesses anti-inflammatory potential as well, we aimed to investigate the involvement and role of CB1 in POI and the possible mechanisms. Specifically, we hypothesized that intestinal and systemic inflammatory responses associated with POI were increased in CB1deficient mice [26], and design a study to elucidate whether activation of CB-1 receptors may serve as a potential target for prevention or treatment of POI.Methods Model of Postoperative IleusAdult female CB1-deficient (CB1?? mice and wild-type littermates (body weight of 25?5 g) in C57BL/6N background as described previously [26] were used in this study. These mice were kept in-house for at least 1 week prior to experiments. Before and during the experiments the animals were housed and maintained under controlled environmental conditions: in plastic sawdust floor cages at constant temperature (22uC) and a 12:12-h light ark cycle with free access to standard laboratory chow and tap water. The animal experiments were carried out in accordance with the national and international guidelines as outlined in the Guide for the Care and Use of Laboratory Animals, using the protocols approved by the Government of Bavaria animal use.